ABSTRACT The distribution of antileucoprotease in the lungs of 25 fetuses of 9-40 weeks' gestation was studied with monoclonal antibodies and an indirect immunoperoxidase technique.
Introduction
The elastase inhibitor antileucoprotease has been localised in the adult human lung in serous cells of bronchial submucosal glands, in bronchial nonciliated epithelial cells, and in bronchiolar Clara and goblet cells, and in association with elastic fibres of alveolar septa and airway and vessel walls.`5 In addition, we have recently shown that the amount of antileucoprotease in distal airways is related to the degree of bronchiolar inflammation and to the degree of loss of alveolar attachment to membranous bronchioles. 6 The presence of this substance in the human adult lung is now well documented, and there is increasing evidence that it has a role in the defence of the lung against proteolytic enzymes.
The distribution of antileucoprotease in the fetal lung was investigated to seek support for the idea that it forms part ofthe first line ofdefence ofthe lung from birth, and also to provide further data on the differentiation of Clara cells in man. containing antileucoprotease appeared in the surface epithelium of the trachea and main and lobar bronchi at the 20th week, but could be detected in bronchiolar epithelium only in specimens of 36 and 40 weeks' gestational age.
Methods

Discussion
So far as we know this is the first report on the distribution ofantileucoprotease during lung development. Our results indicate that in the human fetal lung antileucoprotease containing cells first appear centrally, and then gradually extend to the periphery, in parallel with the centrifugal pattern ofairway differentiation."8 Furthermore, these cells differentiate in the surface epithelium of the trachea and larger bronchi three to four weeks later than in glandular tissue.
Antileucoprotease was not observed in bronchiolar epithelium earlier than the 36th gestational week. In adult bronchioles it has previously been shown to occur in Clara cells and goblet cells.2 Goblet cells are normally sparse in human bronchioles, occurring in appreciable numbers only after irritation and infection. They are therefore unlikely to be present in the fetus, and none was found in our material by the periodic acid-Schiff technique. Consequently it is possible that the antileucoprotease containing cells observed in the bronchioles at 36 and 40 weeks' gestation were Clara cells. This is ofinterest, as data on the differentiation of Clara cells during human lung development are lacking. In rabbits differentiation of these elements occurs over the first four weeks after birth.9 10 In the central airways ofthe adult antileucoprotease is synthesised by the serous cells of submucosal glands.' It probably protects the bronchial lining from damage by elastase, which has been shown to have a harmful effect on the airway epithelium of experimental animals"12 as well as on human airway epithelium in vitro.'314 The results of this investigation indicate that protection against protease is established in the submucosal glands relatively early during lung development.
In the adult distal airways antileucoprotease has been localised not only in Clara and goblet cells but also in association with elastic fibres,25 and a recent morphometric study suggests that it is quantitatively increased when bronchioles are inflamed and their alveolar attachments damaged.6 If antileucoprotease occurs in distal airways only in response to disease and is absent in health, it could be argued that it is merely a non-specific component ofthe inflammatory response. But as it is present in normal fetal and adult bronchioles we believe that in distal airways it is an integral part of the general first line of defence, and that increased amounts are produced as soon as disease develops to minimise tissue damage by release of elastase.
In conclusion, we have established that antileucoprotease is present in the human fetal trachea as early as the 16th week, when the adult pattem of bronchial branching is completed. It extends in a centrifugal manner over the ensuing weeks and reaches the bronchiolar epithelium by the 36th week. Together with data from earlier investigations, these findings suggest that antileucoprotease may have an early and important role in lung defence in man. In addition, they suggest that the Clara cell develops within the last one or two months of human intrauterine life. This latter aspect requires confirmation at the ultrastructural level.
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